Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Jan 11;1(5949):53–55. doi: 10.1136/bmj.1.5949.53

Intravenous salbutamol in management of status asthmaticus.

D H Fitchett, M W McNicol, J F Riordan
PMCID: PMC1672258  PMID: 1109657

Abstract

After the administration of intravenous salbutamol (100-300 mug) to 11 patients admitted to hospital with a severe exacerbation of asthma there was a mean increase in peak expiratory flow of 44% accompanied by a rise in pulse rate of 24 beats/min. Blood gas tensions showed a trend to improvement and there were no serious side effects. It is concluded that intravenous salbutamol is an effective and apparently safe bronchodilator in the management of acutely ill patients with severe asthma.

Full text

PDF
53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins J. V., Clark T. J., Harris P. W., Townsend J. Intravenous corticosteroids in treatment of acute bronchial asthma. Lancet. 1970 Nov 21;2(7682):1047–1049. doi: 10.1016/s0140-6736(70)90283-7. [DOI] [PubMed] [Google Scholar]
  2. Parker S. S., Choo-Kang Y. F., Cooper E. J., Cameron S. J., Grant I. W. Bronchodilator effect of oral salbutamol in asthmatics treated with corticosteroids. Br Med J. 1971 Oct 16;4(5780):139–142. doi: 10.1136/bmj.4.5780.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Tattersfield A. E., McNicol M. W. Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med. 1969 Dec 11;281(24):1323–1326. doi: 10.1056/NEJM196912112812402. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES